Differential cancer diagnosis takes place daily in clinical settings for a better monitoring of patient responses to existing treatments. However outcome of this diagnosis is today still poor. Moreover, current technology to measure biomarker levels is expensive and sophisticated.Most cancer biomarker analysis use blood or biological tissues as the main source of material. These biopsies must be a ...